학술논문
Lenvatinib plus pembrolizumab versus sunitinib for advanced renal cell carcinoma: Japanese patients from the CLEAR study
Document Type
Article
Author
Source
In: Cancer Medicine . (Cancer Medicine, March 2023, 12(6):6902-6912)
Subject
Language
English
ISSN
20457634